Position in KYMR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$22,117,549
+$5,320,289 QoQ
Shares Held
192,880
-4.4% QoQ
Ownership
0.232%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#55
of 275 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. KYMR ranks #33 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in KYMR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,117,549 | 192,880 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $16,797,260 | 201,672 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $15,692,098 | 201,672 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $10,846,767 | 191,639 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,725,054 | 154,103 | Shares | Sole | 2025-08-08 | |
| 2024-09-30 | $4,535,207 | 95,821 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $7,109,224 | 238,165 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $13,197,740 | 328,302 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $8,740,468 | 343,302 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,787,452 | 488,306 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,226,154 | 488,306 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $15,155,033 | 511,476 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,766,440 | 511,476 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $11,965,183 | 549,618 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $9,251,542 | 469,860 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $17,550,653 | 414,713 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $25,574,977 | 402,819 | Shares | Other | 2022-02-10 | |
| 2021-09-30 | $23,201,770 | 394,991 | Shares | Other | 2021-11-09 | |
| 2021-06-30 | $19,933,063 | 410,991 | Shares | Other | 2021-07-20 | |
| 2021-03-31 | $272 | 7 | Shares | Other | 2021-04-29 | |
| No filing history on record for this holder in this stock. | ||||||